ET
ANIP icon

Entropy Technologies’s ANI Pharmaceuticals ANIP Stock Holding History

Entropy Technologies’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$272K Sell
3,282
-3,025
-48% -$243K 0.01% 816
2026
Q1 		$485K Sell
6,307
-2,405
-28% -$188K 0.02% 596
2025
Q4 		$688K Buy
+8,712
New +$754K 0.04% 476
2024
Q2 		– Sell
-4,913
Closed -$340K – 664
2024
Q1 		$340K Sell
4,913
-2,311
-32% -$140K 0.04% 536
2023
Q4 		$398K Buy
+7,224
New +$398K 0.07% 388

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Entropy Technologies's ANIP Position: Q2 2026 in Review

Entropy Technologies reduced its ANI Pharmaceuticals (ANIP) stake by 48% in Q2 2026, selling an estimated $243K and leaving 3,282 shares worth $272K. The position accounts for 0.01% of the portfolio, ranked #816.

Entropy Technologies first reported a position in ANIP in Q4 2023 and has held it in 5 quarters since. The position peaked at $688K in Q4 2025. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Entropy Technologies held 3,282 shares of ANI Pharmaceuticals worth $272K as of Q2 2026.
  • Entropy Technologies sold 3,025 ANI Pharmaceuticals shares in Q2 2026, an estimated $243K.
  • ANI Pharmaceuticals made up 0.01% of Entropy Technologies's portfolio in Q2 2026, its #816 holding.
  • Entropy Technologies first reported a position in ANI Pharmaceuticals in Q4 2023 and has held it in 5 quarters since.
  • Entropy Technologies's ANI Pharmaceuticals position peaked at $688K in Q4 2025.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.